Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$0.18 - $0.48 $101,565 - $270,842
564,255 Added 80.04%
1,269,179 $378,000
Q1 2023

May 08, 2023

SELL
$0.34 - $1.19 $85,185 - $298,149
-250,546 Reduced 26.22%
704,924 $305,000
Q4 2022

Feb 09, 2023

SELL
$1.03 - $2.0 $150,120 - $291,496
-145,748 Reduced 13.24%
955,470 $1.13 Million
Q3 2022

Nov 10, 2022

BUY
$0.42 - $3.92 $409,813 - $3.82 Million
975,746 Added 777.66%
1,101,218 $2.56 Million
Q2 2022

Aug 04, 2022

BUY
N/A
19,363 Added 18.25%
125,472 $277,000
Q1 2022

May 12, 2022

BUY
N/A
106,109 New
106,109 $1.02 Million

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.